Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia

被引：21
|
作者：
Parellada, Eduard [1 ]
Velligan, Dawn I. [2 ]
Emsley, Robin [3 ]
Kissling, Werner [4 ]
机构：
[1] Univ Barcelona, Hosp Clin Barcelona, Dept Psychiat, Clin Schizophrenia Program PEC, E-08036 Barcelona, Spain
[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA
[3] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Psychiat, ZA-7500 Cape Town, South Africa
[4] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Psychiat & Psychotherap, D-81675 Munich, Germany
来源：
SCHIZOPHRENIA RESEARCH AND TREATMENT | 2012年 / 2012卷
关键词：
D O I：
10.1155/2012/318535
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia Practical Considerations
    Kverno, Karan
    Rozenberg, Ilya
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2021, 59 (07) : 7 - 12
  • [42] Effectiveness of risperidone long-acting injection in first-episode schizophrenia: In naturalistic setting
    Kim, Borah
    Lee, Sang-Hyuk
    Choi, Tae Kyou
    Suh, ShinYoung
    Kim, Yong Woo
    Lee, EunHee
    Yook, Ki Hwan
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (05): : 1231 - 1235
  • [43] Delphi Panel on the Relationship Between Long-Acting Injectable Antipsychotics and Longer-Term Functional Recovery in First-Episode and Early-Phase Schizophrenia Patients
    Kane, John M.
    Yildirim, Murat
    Madera-McDonough, Jessica
    Arango, Celso
    Fagiolini, Andrea
    Gorwood, Philip
    Sahota, Navdeep
    Correll, Christoph U.
    CNS SPECTRUMS, 2023, 28 (02) : 253 - 253
  • [44] LONG-ACTING INJECTABLE ANTIPSYCHOTICS Reply
    Limandri, Barbara J.
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2019, 57 (11) : 5 - +
  • [45] Long-acting injectable (LAI) antipsychotics in the long-term treatment of schizophrenia
    Fleischhacker, Wolfgang
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 321 - 322
  • [46] Analysis of Oral versus Long-acting Injectable Antipsychotics in the Maintenance of Schizophrenia
    Vasiliu, O.
    EUROPEAN PSYCHIATRY, 2022, 65 : S322 - S322
  • [47] LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA: A 18 MONTHS STUDY
    Romero Guillena, S. L.
    Gotor, F.
    Plasencia Garcia de Diego, B. O.
    Navarro Pablo, R.
    Santamaria, O.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [48] Efficacy and tolerability of paliperidone palmitate long-acting injectable antipsychotic in first-episode schizophrenic patients
    Petric, D.
    Racki, V.
    Graovac, M.
    Kastelan, A.
    Grahovac, T.
    Vucic-Peitl, M.
    Franciskovic, T.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 150 - 151
  • [49] Using Long-Acting Injectable Antipsychotics to Enhance the Potential for Recovery in Schizophrenia
    Correll, Christoph U.
    Lauriello, John
    JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (04)
  • [50] Relevance of study design for the effectiveness of long-acting injectable antipsychotics in schizophrenia
    Correll, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S633 - S634
12345